Logo image of JBTM

JBT MAREL CORP (JBTM) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:JBTM - US4778391049 - Common Stock

155.64 USD
+1.25 (+0.81%)
Last: 12/22/2025, 12:40:12 PM
Fundamental Rating

3

Taking everything into account, JBTM scores 3 out of 10 in our fundamental rating. JBTM was compared to 132 industry peers in the Machinery industry. JBTM may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, JBTM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

JBTM had positive earnings in the past year.
JBTM had a positive operating cash flow in the past year.
JBTM had positive earnings in each of the past 5 years.
Each year in the past 5 years JBTM had a positive operating cash flow.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

The Return On Assets of JBTM (-1.35%) is worse than 71.97% of its industry peers.
The Return On Equity of JBTM (-2.50%) is worse than 71.21% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.95%, JBTM is doing worse than 68.94% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for JBTM is below the industry average of 10.27%.
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROIC 1.95%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

JBTM's Profit Margin has declined in the last couple of years.
JBTM's Operating Margin of 4.81% is on the low side compared to the rest of the industry. JBTM is outperformed by 62.12% of its industry peers.
In the last couple of years the Operating Margin of JBTM has declined.
JBTM has a Gross Margin of 35.80%. This is in the better half of the industry: JBTM outperforms 65.91% of its industry peers.
JBTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.81%
PM (TTM) N/A
GM 35.8%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), JBTM is destroying value.
Compared to 1 year ago, JBTM has about the same amount of shares outstanding.
The number of shares outstanding for JBTM has been increased compared to 5 years ago.
JBTM has a worse debt/assets ratio than last year.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

JBTM has an Altman-Z score of 1.96. This is not the best score and indicates that JBTM is in the grey zone with still only limited risk for bankruptcy at the moment.
JBTM's Altman-Z score of 1.96 is on the low side compared to the rest of the industry. JBTM is outperformed by 63.64% of its industry peers.
JBTM has a debt to FCF ratio of 6.97. This is a slightly negative value and a sign of low solvency as JBTM would need 6.97 years to pay back of all of its debts.
JBTM has a Debt to FCF ratio of 6.97. This is comparable to the rest of the industry: JBTM outperforms 46.97% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that JBTM is not too dependend on debt financing.
JBTM's Debt to Equity ratio of 0.43 is in line compared to the rest of the industry. JBTM outperforms 53.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Altman-Z 1.96
ROIC/WACC0.22
WACC9.02%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

JBTM has a Current Ratio of 0.93. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of JBTM (0.93) is worse than 88.64% of its industry peers.
JBTM has a Quick Ratio of 0.93. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.53, JBTM is not doing good in the industry: 89.39% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.53
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

JBTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.08%, which is quite impressive.
The Earnings Per Share has been growing slightly by 0.52% on average over the past years.
JBTM shows a strong growth in Revenue. In the last year, the Revenue has grown by 92.43%.
The Revenue has been decreasing by -2.48% on average over the past years.
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%

3.2 Future

JBTM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.91% yearly.
JBTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.83% yearly.
EPS Next Y25.32%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
EPS Next 5YN/A
Revenue Next Year117.04%
Revenue Next 2Y50.56%
Revenue Next 3Y33.89%
Revenue Next 5Y4.83%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

JBTM is valuated quite expensively with a Price/Earnings ratio of 25.51.
Compared to the rest of the industry, the Price/Earnings ratio of JBTM is on the same level as its industry peers.
JBTM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.39, which is the current average of the S&P500 Index.
JBTM is valuated rather expensively with a Price/Forward Earnings ratio of 19.74.
The rest of the industry has a similar Price/Forward Earnings ratio as JBTM.
When comparing the Price/Forward Earnings ratio of JBTM to the average of the S&P500 Index (23.84), we can say JBTM is valued inline with the index average.
Industry RankSector Rank
PE 25.51
Fwd PE 19.74
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

68.18% of the companies in the same industry are cheaper than JBTM, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JBTM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 29.57
EV/EBITDA 24.87
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as JBTM's earnings are expected to grow with 23.91% in the coming years.
PEG (NY)1.01
PEG (5Y)49.28
EPS Next 2Y24.33%
EPS Next 3Y23.91%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.26%, JBTM is not a good candidate for dividend investing.
JBTM's Dividend Yield is comparable with the industry average which is at 1.04.
Compared to an average S&P500 Dividend Yield of 1.87, JBTM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.26%

5.2 History

The dividend of JBTM has a limited annual growth rate of 0.48%.
JBTM has been paying a dividend for over 5 years, so it has already some track record.
JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.48%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

JBTM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of JBTM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-17.36%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

JBT MAREL CORP

NYSE:JBTM (12/22/2025, 12:40:12 PM)

155.64

+1.25 (+0.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)05-04 2026-05-04
Inst Owners99.26%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner Change-7.52%
Market Cap8.09B
Revenue(TTM)3.26B
Net Income(TTM)-110.60M
Analysts80
Price Target159.94 (2.76%)
Short Float %5.95%
Short Ratio5.57
Dividend
Industry RankSector Rank
Dividend Yield 0.26%
Yearly Dividend0.41
Dividend Growth(5Y)0.48%
DP-17.36%
Div Incr Years0
Div Non Decr Years4
Ex-Date12-15 2025-12-15 (0.1)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.24%
Min EPS beat(2)14.08%
Max EPS beat(2)26.4%
EPS beat(4)3
Avg EPS beat(4)11.49%
Min EPS beat(4)-8.58%
Max EPS beat(4)26.4%
EPS beat(8)5
Avg EPS beat(8)4.11%
EPS beat(12)9
Avg EPS beat(12)6.09%
EPS beat(16)11
Avg EPS beat(16)6.44%
Revenue beat(2)2
Avg Revenue beat(2)3.62%
Min Revenue beat(2)2.12%
Max Revenue beat(2)5.11%
Revenue beat(4)3
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-6.26%
Max Revenue beat(4)5.11%
Revenue beat(8)4
Avg Revenue beat(8)-1.54%
Revenue beat(12)4
Avg Revenue beat(12)-4.62%
Revenue beat(16)5
Avg Revenue beat(16)-3.94%
PT rev (1m)8.29%
PT rev (3m)9.04%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)0.19%
EPS NY rev (1m)6.46%
EPS NY rev (3m)6.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.9%
Revenue NY rev (1m)1.75%
Revenue NY rev (3m)1.77%
Valuation
Industry RankSector Rank
PE 25.51
Fwd PE 19.74
P/S 2.48
P/FCF 29.57
P/OCF 22.9
P/B 1.83
P/tB N/A
EV/EBITDA 24.87
EPS(TTM)6.1
EY3.92%
EPS(NY)7.88
Fwd EY5.06%
FCF(TTM)5.26
FCFY3.38%
OCF(TTM)6.8
OCFY4.37%
SpS62.69
BVpS85.06
TBVpS-22.35
PEG (NY)1.01
PEG (5Y)49.28
Graham Number108.05
Profitability
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROCE 2.39%
ROIC 1.95%
ROICexc 1.98%
ROICexgc 10.75%
OM 4.81%
PM (TTM) N/A
GM 35.8%
FCFM 8.4%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
ROICexc(3y)7.1%
ROICexc(5y)8.09%
ROICexgc(3y)24.27%
ROICexgc(5y)25.88%
ROCE(3y)6.33%
ROCE(5y)8.04%
ROICexgc growth 3Y-1.29%
ROICexgc growth 5Y-6.67%
ROICexc growth 3Y-5.85%
ROICexc growth 5Y-12.74%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Debt/EBITDA 5.04
Cap/Depr 36%
Cap/Sales 2.45%
Interest Coverage 250
Cash Conversion 93.41%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.53
Altman-Z 1.96
F-Score3
WACC9.02%
ROIC/WACC0.22
Cap/Depr(3y)71.26%
Cap/Depr(5y)66.65%
Cap/Sales(3y)3.61%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
EPS Next Y25.32%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
EPS Next 5YN/A
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%
Revenue Next Year117.04%
Revenue Next 2Y50.56%
Revenue Next 3Y33.89%
Revenue Next 5Y4.83%
EBIT growth 1Y-4.04%
EBIT growth 3Y-3.08%
EBIT growth 5Y-9.84%
EBIT Next Year200.73%
EBIT Next 3Y57.39%
EBIT Next 5YN/A
FCF growth 1Y328.68%
FCF growth 3Y4%
FCF growth 5Y22.04%
OCF growth 1Y167.78%
OCF growth 3Y1.15%
OCF growth 5Y16.21%

JBT MAREL CORP / JBTM FAQ

What is the fundamental rating for JBTM stock?

ChartMill assigns a fundamental rating of 3 / 10 to JBTM.


What is the valuation status for JBTM stock?

ChartMill assigns a valuation rating of 3 / 10 to JBT MAREL CORP (JBTM). This can be considered as Overvalued.


Can you provide the profitability details for JBT MAREL CORP?

JBT MAREL CORP (JBTM) has a profitability rating of 3 / 10.


What is the valuation of JBT MAREL CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for JBT MAREL CORP (JBTM) is 25.51 and the Price/Book (PB) ratio is 1.83.


What is the earnings growth outlook for JBT MAREL CORP?

The Earnings per Share (EPS) of JBT MAREL CORP (JBTM) is expected to grow by 25.32% in the next year.